Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Xvivo Perfusion AB (XVIPF)
OTHER OTC:XVIPF
Xvivo Perfusion AB (XVIPF) Stock Price & Analysis
4 Followers
XVIPF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$11.15 - $31.60
Previous Close$23.73
Volume100.00
Average Volume (3M)260.00
Market Cap
$705.67M
Enterprise Value$675.80M
Total Cash (Recent Filing)kr314.56M
Total Debt (Recent Filing)kr5.54M
Price to Earnings (P/E)377.8
Beta1.42
Next Earnings
Apr 24, 2023EPS Estimate
$0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.06
Shares Outstanding29,831,919
10 Day Avg. Volume65
30 Day Avg. Volume260
Standard Deviation0.18
R-Squared0.02
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)21.92
Price to Sales (P/S)2.38
Price to Cash Flow (P/CF)1272.50
P/FCF Ratio1170.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
XVIPF FAQ
What was Xvivo Perfusion AB’s price range in the past 12 months?
Xvivo Perfusion AB lowest stock price was $11.15 and its highest was $31.60 in the past 12 months.
What is Xvivo Perfusion AB’s market cap?
Currently, no data Available
When is Xvivo Perfusion AB’s upcoming earnings report date?
Xvivo Perfusion AB’s upcoming earnings report date is Apr 24, 2023 which is in 30 days.
How were Xvivo Perfusion AB’s earnings last quarter?
Xvivo Perfusion AB released its earnings results on Jan 26, 2023. The company reported $0.013 earnings per share for the quarter, missing the consensus estimate of $0.038 by -$0.025.
Is Xvivo Perfusion AB overvalued?
According to Wall Street analysts Xvivo Perfusion AB’s price is currently Overvalued.
Does Xvivo Perfusion AB pay dividends?
Xvivo Perfusion AB does not currently pay dividends.
What is Xvivo Perfusion AB’s EPS estimate?
Xvivo Perfusion AB’s EPS estimate is $0.04.
How many shares outstanding does Xvivo Perfusion AB have?
Xvivo Perfusion AB has 29,561,968 shares outstanding.
What happened to Xvivo Perfusion AB’s price movement after its last earnings report?
Xvivo Perfusion AB reported an EPS of $0.013 in its last earnings report, missing expectations of $0.038. Following the earnings report the stock price went down -3.268%.
Which hedge fund is a major shareholder of Xvivo Perfusion AB?
Currently, no hedge funds are holding shares in XVIPF
---
Xvivo Perfusion AB Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-4.89%
12-Months-Change
Fundamentals
Return on Equity
1.33%
Trailing 12-Months
Asset Growth
-2.38%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Xvivo Perfusion AB
Xvivo Perfusion AB is a medical technology company which develops and markets innovative system solutions for the preservation and evaluation of donated organs outside the body awaiting transplantation. The company supply transplantation clinics worldwide with advanced technological products for the preservation and evaluation of lungs.
---
---